TREA

86885795 - TALLARIG

Follow

Information

  • Trademark
  • 86885795
  • Serial Number
    86885795
  • Filing Date
    January 25, 2016
    8 years ago
  • Transaction Date
    August 26, 2019
    5 years ago
  • Status Date
    August 26, 2019
    5 years ago
  • Published for Opposition Date
    May 31, 2016
    8 years ago
  • Location Date
    January 31, 2019
    5 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    MCCRAY, RENEE D
  • Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
TALLARIG
Case File Statements
  • GS0051: Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
  • TR0010: The wording "TALLARIG" has no meaning in a foreign language.
Case File Event Statements
  • 8/26/2019 - 5 years ago
    38 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 8/26/2019 - 5 years ago
    37 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 2/2/2019 - 5 years ago
    36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/1/2019 - 5 years ago
    35 - EXTENSION 5 GRANTED Type: EX5G
  • 1/22/2019 - 5 years ago
    34 - EXTENSION 5 FILED Type: EXT5
  • 1/31/2019 - 5 years ago
    33 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/22/2019 - 5 years ago
    32 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/15/2018 - 6 years ago
    31 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 7/19/2018 - 6 years ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/17/2018 - 6 years ago
    29 - EXTENSION 4 GRANTED Type: EX4G
  • 7/17/2018 - 6 years ago
    28 - EXTENSION 4 FILED Type: EXT4
  • 7/17/2018 - 6 years ago
    27 - TEAS EXTENSION RECEIVED Type: EEXT
  • 1/16/2018 - 6 years ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/12/2018 - 6 years ago
    25 - EXTENSION 3 GRANTED Type: EX3G
  • 1/12/2018 - 6 years ago
    24 - EXTENSION 3 FILED Type: EXT3
  • 1/12/2018 - 6 years ago
    23 - TEAS EXTENSION RECEIVED Type: EEXT
  • 6/15/2017 - 7 years ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/13/2017 - 7 years ago
    21 - EXTENSION 2 GRANTED Type: EX2G
  • 6/13/2017 - 7 years ago
    20 - EXTENSION 2 FILED Type: EXT2
  • 6/13/2017 - 7 years ago
    19 - TEAS EXTENSION RECEIVED Type: EEXT
  • 1/7/2017 - 7 years ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/5/2017 - 7 years ago
    17 - EXTENSION 1 GRANTED Type: EX1G
  • 1/5/2017 - 7 years ago
    16 - EXTENSION 1 FILED Type: EXT1
  • 1/5/2017 - 7 years ago
    15 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/26/2016 - 8 years ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/31/2016 - 8 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/31/2016 - 8 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/11/2016 - 8 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/26/2016 - 8 years ago
    10 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 4/19/2016 - 8 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 4/2/2016 - 8 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/1/2016 - 8 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/1/2016 - 8 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/1/2016 - 8 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/1/2016 - 8 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/29/2016 - 8 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/29/2016 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 1/28/2016 - 8 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP